Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

BACKGROUND: Many high-risk coronary heart disease (CHD) patients on statin monotherapy do not achieve guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals, and combination lipid-lowering therapy may be considered for these individuals. The effect of adding ezetimibe to simvastatin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Foody, JoAnne M, Toth, Peter P, Tomassini, Joanne E, Sajjan, Shiva, Ramey, Dena R, Neff, David, Tershakovec, Andrew M, Hu, Henry, Tunceli, Kaan
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2013
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833706/
https://ncbi.nlm.nih.gov/pubmed/24265554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S49840
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk